main menu
Cell&Brain Co., Ltd
Overview
CEO
History
Mission & Vision
Direction
Research and development
Pipelines
Core Technology
Publications
Patents
Partnerships
Investors
Stock Information
Customer support
Notice&News
Contact US
KOREAN
ENGLISH
메뉴
메뉴
HOME
Cell&Brain Co., Ltd
Overview
CEO
History
Mission & Vision
Direction
Research and development
Pipelines
Core Technology
Publications
Patents
Partnerships
Investors
Stock Information
Customer support
Notice&News
Contact US
Close
Cell&Brain Co., Ltd
Overview
CEO
History
Mission & Vision
Direction
Research and development
Pipelines
Core Technology
Publications
Patents
Partnerships
Investors
Stock Information
Customer support
Notice&News
Contact US
Close
Cell&Brain Co., Ltd
Global innovative bio technology company leading the development of gene-cell therapy
History
2022
09.
Relocation of R&D center
02.
Technology transferred (Registered patent on. 10-1850780
in Industry-Academic Cooperation Foundation of Ajou University)
2021
12.
SeriesAFund Raised(5.0 Billion KRW)
08.
PCT Application(PCT/KR2021/011553)
06.
Extend Venture Company Certification(2021.04 ~ 2024.04)
04.
Patent Registration.(10-2247812)
03.
Started IIT(Investigator Initiated Trial) for Brain Tumor(GBM)
02.
Acquired all technology related Brain Tumor(GBM)Treatment
from Hanmi Pharm. Co., Ltd.
02.
Issue Common Stock(Hanmi Pharm. Co., Ltd)
2020
12.
Patent & PCT Application
06.
Developed gene integration siteanalyzing pipeline for
gene transferred stem cell therapy
05.
Developed Gene-Stem Cell Therapy platform technology
04.
Established branch in Gyeonggi-do
03.
Developed lentivirus-based vector manufacturing technology
2019
12.
Technology transferred (Registered patent on. 10-1446711
in academic-industrial cooperation group at Ajou University)
12.
New patent application
10.
US Patent Prosecution Highway(PPH)
10.
Attracted the investment in PreA
08.
acquire recognition of a company Research Center
04.
Certified as venture company
2018
11.
Registered the Research Institute Company
08.
Established the department exclusively responsible
for research and development
07.
Signed a contract for a Non-exclusive license agreement with Ajou University
03.
Established the company